{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -6.0013027, "regularMarketPrice": 0.4323, "exchange": "NGM", "shortName": "ZyVersa Therapeutics, Inc.", "longName": "ZyVersa Therapeutics, Inc.", "messageBoardId": "finmb_268178409", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "currency": "USD", "marketState": "PRE", "firstTradeDateMilliseconds": 1644589800000, "priceHint": 4, "preMarketChange": 0.010099977, "preMarketChangePercent": 2.3368757, "preMarketTime": 1684226076, "preMarketPrice": 0.4423, "fiftyTwoWeekLowChange": 0.0063000023, "fiftyTwoWeekLowChangePercent": 0.0147887375, "fiftyTwoWeekRange": "0.426 - 25.0", "fiftyTwoWeekHighChange": -24.5677, "fiftyTwoWeekHighChangePercent": -0.982708, "fiftyTwoWeekLow": 0.426, "fiftyTwoWeekHigh": 25.0, "trailingAnnualDividendRate": 0.0, "epsTrailingTwelveMonths": -1.07, "sharesOutstanding": 20227400, "bookValue": 10.819, "fiftyDayAverage": 1.49894, "fiftyDayAverageChange": -1.06664, "fiftyDayAverageChangePercent": -0.7115962, "twoHundredDayAverage": 5.856665, "twoHundredDayAverageChange": -5.424365, "twoHundredDayAverageChangePercent": -0.9261866, "marketCap": 9696878, "priceToBook": 0.039957482, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.02759999, "regularMarketTime": 1684180780, "regularMarketDayHigh": 0.4589, "regularMarketDayRange": "0.426 - 0.4589", "regularMarketDayLow": 0.426, "regularMarketVolume": 1195191, "regularMarketPreviousClose": 0.4599, "bid": 0.0, "ask": 0.0, "bidSize": 12, "askSize": 12, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 0.4557, "averageDailyVolume3Month": 1174840, "averageDailyVolume10Day": 2637000, "trailingAnnualDividendYield": 0.0, "displayName": "ZyVersa Therapeutics", "symbol": "ZVSA"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2200 N. Commerce Parkway", "address2": "Suite 208", "city": "Weston", "state": "FL", "zip": "33326", "country": "United States", "phone": "(754) 231-1688", "website": "https://www.zyversa.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator, which is in Phase 2a clinical trial to the treatment of multiple renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic nephropathy; and IC 100, a monoclonal antibody inflammasome ASC inhibitor that is in preclinical stage for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen C. Glover", "age": 62, "title": "Co-Founder, Chairman, CEO & Pres", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": {"raw": 450500, "fmt": "450.5k", "longFmt": "450,500"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter  Wolfe", "age": 54, "title": "CFO & Sec.", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 275000, "fmt": "275k", "longFmt": "275,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nicholas A. LaBella Jr., MS, RPh.", "age": 66, "title": "Chief Scientific Officer and Sr. VP of R&D", "yearBorn": 1956, "fiscalYear": 2022, "totalPay": {"raw": 325000, "fmt": "325k", "longFmt": "325,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Karen A. Cashmere", "age": 70, "title": "Chief Commercial Officer", "yearBorn": 1952, "fiscalYear": 2022, "totalPay": {"raw": 300000, "fmt": "300k", "longFmt": "300,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Melda  Uzbil O'connell", "title": "Sr. VP of Corp. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pablo A. Guzman FACC, M.D.", "age": 72, "title": "Chief Medical Officer, Sr. VP of Medical Affairs & Chairman of Renal Scientific Advisory Board", "yearBorn": 1950, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}